Most Pivotal Trials of New Drugs Recruit From Low-, Middle-Income Countries
MONDAY, Nov. 21, 2022 (HealthDay News) — Most pivotal trials of new cancer, cardiovascular, and neurologic drugs recruit from low- and middle-income countries (LMIC), according to a study published online Nov. 22 in the Annals of Internal Medicine.Fa…
Learn MoreVitamin D Supplements Do Not Reduce Asthma Exacerbations Overall
MONDAY, Nov. 21, 2022 (HealthDay News) — Vitamin D supplementation does not reduce the risk for asthma exacerbation in children overall, but does reduce the risk in those with low serum 25-hydroxyvitamin D (25[OH]D) concentrations, according to a rev…
Learn MoreStudy Explores Weight Terminology That Youth Prefer, Dislike
MONDAY, Nov. 21, 2022 (HealthDay News) — Many youth have a preference and dislike for terms of weight terminology, with differences seen across sex, sexual orientation, race/ethnicity, and weight status, according to a study published online Nov. 21 …
Learn MoreTreatment-Related Adverse Events of Antibody Drug Conjugates Identified
MONDAY, Nov. 21, 2022 (HealthDay News) — Adverse effects associated with antibody-drug conjugates (ADCs) have been described in a review and meta-analysis published online Nov. 21 in Cancer.Youwen Zhu, from Central South University in Changsha, China…
Learn MoreGuidance Provided for Identifying, Managing CP in Primary Care
MONDAY, Nov. 21, 2022 (HealthDay News) — In a clinical report issued by the American Academy of Pediatrics and the American Academy for Cerebral Palsy and Developmental Medicine, published online Nov. 21 in Pediatrics, recommendations are presented f…
Learn MoreACR: Long-Term Safety Demonstrated for Anifrolumab in Lupus
MONDAY, Nov. 21, 2022 (HealthDay News) — For patients with systemic lupus erythematosus (SLE), anifrolumab is safe in the long term, according to a study published online Nov. 11 in Arthritis & Rheumatology to coincide with the annual meeting of the …
Learn MoreTreatment Without ADT Delays Initiation of Systemic Therapy in Prostate Cancer
MONDAY, Nov. 21, 2022 (HealthDay News) — For prostate cancer patients with a solitary oligometastatic lesion, metastasis-directed therapy without androgen deprivation therapy (ADT) can delay initiation of systemic therapy, according to a study publis…
Learn MoreThermal Images Differentiate Healed From Unhealed Wounds
MONDAY, Nov. 21, 2022 (HealthDay News) — Thermal images taken in home settings at week 0 can differentiate between healed and unhealed wounds on venous leg ulcers, according to a study published online Oct. 26 in Scientific Reports.Quoc Cuong Ngo, Ph…
Learn MoreMore Than 12 Percent Develop De Novo Postpartum Hypertension
MONDAY, Nov. 21, 2022 (HealthDay News) — In the year after delivery, more than 12 percent of patients with normotensive pregnancies experience de novo postpartum hypertension (dn-PPHTN), according to a study published online Nov. 15 in Hypertension.S…
Learn MoreSubretinal Drusenoid Deposits Linked to High-Risk Vascular Disease in AMD
FRIDAY, Nov. 18, 2022 (HealthDay News) — In patients with age-related macular degeneration (AMD), subretinal drusenoid deposits (SDD) are associated with high-risk vascular diseases (HRVD), according to a study published online Nov. 17 in BMJ Open Op…
Learn More